Leveraging Bioinformatics and Machine Learning for Identifying Prognostic Biomarkers and Predicting Clinical Outcomes in Lung Adenocarcinoma
Genes · 2024
DOI: 10.3390/genes15121497 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2024. Verfasst von Kaida Cai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, School of Public Health, Southeast University, Nanjing 210009, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Biomarkers, Tumor, Lung Neoplasms, Machine Learning. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Background/Objectives: There exist significant challenges for lung adenocarcinoma (LUAD) due to its poor prognosis and limited treatment options, particularly in the advanced stages. It is crucial to identify genetic biomarkers for improving outcome predictions and guiding personalized therapies.
Methods
In this study, we utilize a multi-step approach that combines principled sure independence screening, penalized regression methods and information gain to identify the key genetic features of the ultra-high dimensional RNA-sequencing data from LUAD patients. We then evaluate three methods of survival analysis: the Cox model, survival tree, and random survival forests (RSFs), to compare their predictive performance. Additionally, a protein–protein interaction network is used to explore the biological significance of identified genes.
Results
DKK1 and TNS4 are consistently selected as significant predictors across all feature selection methods. The Kaplan–Meier method shows that high expression levels of these genes are strongly correlated with poorer survival outcomes, suggesting their potential as prognostic biomarkers. RSF outperforms Cox and survival tree methods, showing higher AUC and C-index values. The protein–protein interaction network highlights key nodes such as VEGFC and LAMA3, which play central roles in LUAD progression.
Conclusions
Our findings provide valuable insights into the genetic mechanisms of LUAD. These results contribute to the development of more accurate prognostic tools and personalized treatment strategies for LUAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, School of Public Health, Southeast University, Nanjing 210009, China.
- Department of Statistics and Actuarial Science, School of Mathematics, Southeast University, Nanjing 211189, China.
- Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China.
- Key Laboratory of Measurement and Control of Complex Systems of Engineering, Ministry of Education, Southeast University, Nanjing 210096, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Fundamental Research Funds for the Central Universities
- Zhishan Young Scholar Award
Zitieren
APA
Cai, K., Fu, W., Liu, H., Yang, X., Wang, Z., & Zhao, X. (2024). Leveraging Bioinformatics and Machine Learning for Identifying Prognostic Biomarkers and Predicting Clinical Outcomes in Lung Adenocarcinoma. Genes. https://doi.org/10.3390/genes15121497
Vancouver
Cai K, Fu W, Liu H, Yang X, Wang Z, Zhao X. Leveraging Bioinformatics and Machine Learning for Identifying Prognostic Biomarkers and Predicting Clinical Outcomes in Lung Adenocarcinoma. Genes. 2024. doi:10.3390/genes15121497
BibTeX
@article{Cai2024,
author = {Cai, Kaida and Fu, Wenzhi and Liu, Hanwen and Yang, Xiaofang and Wang, Zhengyan and Zhao, Xin},
title = {Leveraging Bioinformatics and Machine Learning for Identifying Prognostic Biomarkers and Predicting Clinical Outcomes in Lung Adenocarcinoma},
journal = {Genes},
year = {2024},
doi = {10.3390/genes15121497}
}
EUVIMED